Results 91 to 100 of about 59,323 (260)

Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma

open access: yes, 2011
Hatem M Marey, Amin F EllakwaDepartment of Ophthalmology, Faculty of Medicine, Menoufiya University, Shibin el Kom, EgyptPurpose: To demonstrate the role of intravitreal bevacizumab in regression of iris neovascularization, and intraocular pressure (IOP)
Marey HM, Ellakwa AF
core  

The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines

open access: yes, 2005
Objevtive: to assess whether microinjecting epirubicin into cells showing multidrug resistance (MDR, common to many cancers, including bladder cancer, with resistance to, e.g.
Birch, B.R   +5 more
core   +1 more source

The efficacy and safety of reducing intraocular pressure to single‐digit levels in Normal‐tension glaucoma: A systematic review and meta‐analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose This systematic review and meta‐analysis aim to evaluate the efficacy and safety of further lowering intraocular pressure (IOP) to single‐digit levels in treated patients with progressive normal‐tension glaucoma (NTG). Methods A literature search was conducted in MEDLINE (via PubMed), Scopus and Web of Science. We selected studies that
Beatriz Araújo‐Azevedo   +2 more
wiley   +1 more source

Trabeculectomy with mitomycin C(MMC)

open access: yes, 1994
의학과/석사[한글] Mitomycin C는 섬유모세포의 증식을 억제하는 효과가 있어 섬휴주절제술의 보조제로 사용되고 있다. Mitomycin C가 섬유주절제술의 결과에 미치는 영향을 알아보기 위하여 mitomycin C를 사용하고 섬유주절제술을 받은 74명(95안)과 mitomycin C를 사용하지 않고 섬유주절제술을 받은 69명 (90안)을 비교 검토하였다.
조용수
core  

Exploring Patterns of Mitomycin C Use in Community Practice Urology

open access: yes, 2018
Introduction: Although evidence supports the use of mitomycin C after transurethral bladder tumor resection in reducing recurrent disease, its adoption has been limited.
TİNAY, İLKER
core   +1 more source

A prospective randomised comparison of two different stenting sutures when using the Baerveldt 101–350 aqueous shunt – Lab transition to clinical process

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The Baerveldt glaucoma drainage implant (BGI 101–350) is one of the most effective treatment options for managing refractory glaucoma. To mitigate early hypotony in non‐valved implants, intraluminal occluding sutures (IOSs) are commonly used.
Evripidis Sykakis   +7 more
wiley   +1 more source

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review [PDF]

open access: yesInvestigative and Clinical Urology, 2020
Stefanie Schmidt   +9 more
doaj   +1 more source

Prevention of Intraabdominal Adhesions: An Experimental Study Using Mitomycin-C and 4% Icodextrin

open access: yesBalkan Medical Journal, 2017
Background: Intraabdominal adhesions remain a significant cause of morbidity and mortality. Moreover, intraabdominal adhesions can develop in more than 50% of abdominal operations.
Murat Urkan   +6 more
doaj   +1 more source

Vision‐related quality of life following trabeculectomy versus Baerveldt glaucoma implant: Five‐year results from a randomized clinical trial

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To assess the vision‐related quality of life (VRQoL) in glaucoma patients over 5 years after primary Baerveldt glaucoma implant (BGI) or trabeculectomy (TE) using a secondary analysis of a randomized clinical trial. Methods Patients were randomized to undergo TE or receive a BGI.
Ionela Popescu‐Giovanitsas   +4 more
wiley   +1 more source

Structure-activity relationships for mitomycin C and mitomycin A analogues

open access: yes, 1996
A set of 30 mitomycin C and mitomycin A analogues, including 5 new compounds, was screened against 3 different solid human tumor cell lines using the MTT tetrazolium dye assay.
Kunz, Kenneth Robert
core  

Home - About - Disclaimer - Privacy